GAK (Cyclin G-Associated Kinase)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GAK Gene</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">LRRK2</td>
<td>Physical binding</td>
</tr>
<tr>
<td class="label">Clathrin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Hsc70</td>
<td>Physical binding</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">APP</td>
<td>Indirect (trafficking)</td>
</tr>
<tr>
<td class="label">α-Synuclein</td>
<td>Indirect (trafficking)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">26 edges</a></td>
</tr>
</table>
Overview
Mermaid diagram (expand to render)
GAK (Cyclin G-Associated Kinase) is a serine/threonine kinase encoded by the GAK gene on chromosome 6p21.1. Originally identified as a cyclin-dependent kinase (CDK) partner, GAK plays critical roles in endocytosis, clathrin-mediated vesicle trafficking, and autophagy["@kaneko2010"]. Recent research has implicated GAK in the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), making it a potential therapeutic target["@zhou2021"].
Gene Structure and Expression
The GAK gene spans approximately 45 kb and contains 43 exons. It encodes a protein of 1,505 amino acids with a molecular weight of approximately 165 kDa. GAK is ubiquitously expressed with highest levels in the brain, particularly in the hippocampus and basal ganglia[@tan2015].
Key structural features include:
- N-terminal kinase domain: Serine/threonine kinase activity
- Central clathrin-binding domain: Mediates interaction with clathrin-coated pits
- C-terminal Hsc70-binding domain: Regulates chaperone-mediated protein folding
Molecular Function
Endocytosis and Vesicle Trafficking
GAK is a central regulator of clathrin-mediated endocytosis. It associates with clathrin-coated vesicles and recruits accessory proteins including AP-2, epsin, and amphiphysin to forming vesicles[@zhang2014]. GAK phosphorylates several components of the endocytic machinery, including dynamin I, which is essential for vesicle scission.
Autophagy Regulation
GAK interacts with the autophagy initiation complex through direct binding to ULK1 (Unc-51 Like Kinase 1) and ATG14L. This interaction is regulated by mTORC1 signaling, positioning GAK as a node connecting nutrient sensing with autophagosome formation[@egan2015]. GAK also participates in later stages of autophagy by regulating the fusion of autophagosomes with lysosomes through interactions with the HOPS complex.
Protein Quality Control
As a partner of Hsc70 (heat shock cognate 70 kDa protein), GAK contributes to protein quality control by facilitating the degradation of misfolded proteins through both autophagy and the proteasome[@kim2019].
Role in Neurodegeneration
Alzheimer's Disease
In AD, GAK is implicated through several mechanisms:
Amyloid processing: GAK regulates the trafficking of amyloid precursor protein (APP) through endocytic compartments. Altered GAK expression affects β-amyloid (Aβ) production, with some studies showing increased GAK activity leading to enhanced amyloidogenesis[@vassar2014].
Tau pathology: GAK interacts with tau protein and affects its phosphorylation state through modulation of GSK-3β activity. This connection suggests a role in neurofibrillary tangle formation.
Autophagy impairment: In AD brains, GAK expression is altered, contributing to the well-documented autophagy-lysosomal dysfunction that characterizes the disease.Parkinson's Disease
GAK has emerged as a genetic risk factor for PD:
LRRK2 interaction: GAK physically interacts with LRRK2 (Leucine-Rich Repeat Kinase 2), a major PD-causing gene. GAK is phosphorylated by LRRK2, and this interaction affects endocytic trafficking of dopamine receptors[@lee2020].
α-Synuclein trafficking: GAK regulates the endocytic pathway that controls α-synuclein clearance. Dysregulation of GAK may contribute to the accumulation of toxic α-synuclein aggregates.
Mitochondrial function: Altered GAK expression affects mitochondrial dynamics and can lead to increased oxidative stress, a hallmark of PD pathogenesis.Clinical Significance
Genetic Associations
Genome-wide association studies (GWAS) have identified GAK variants as risk factors for:
- Parkinson's disease (odds ratio ~1.2-1.4)[@nalls2014]
- Alzheimer's disease (particularly in Asian populations)
Therapeutic Implications
GAK represents a promising therapeutic target:
Kinase inhibitors: Small molecule inhibitors of GAK kinase activity are being developed for potential neuroprotective therapy.
Modulation of autophagy: Compounds that enhance GAK-mediated autophagy could help clear toxic protein aggregates.
Endocytic pathway modulation: Targeting GAK-endocytic interactions may normalize trafficking defects in neurodegeneration.Key Interactions
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Kaneko, Y., et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/19878744/)
[Zhou, X., et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33496923/)
[Tan, E., et al, (2015) (2015)](https://doi.org/10.1007/s40263-015-0284-5)
[Zhang, C., et al, (2014) (2014)](https://doi.org/10.1074/jbc.M113.514017)
[Egan, D., et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25720963/)
[Kim, S., et al, (2019) (2019)](https://doi.org/10.1016/j.pneurobio.2019.101664)
[Unknown, Vassar, R. (2014). BACE1 inhibitor drugs in clinical trials for Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25464037/)
[Lee, H., et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32127722/)
[Nalls, M.A., et al, (2014) (2014)](https://doi.org/10.1038/ng.3039)Pathway Diagram
The following diagram shows the key molecular relationships involving GAK Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)